AGX

SEC source: 0001415889-23-006711 · form4-04192023_040411.xml · derivative · entry 2

Griffin William F Jr · CIK 0001384123 · Director · GEMMA, NON-EXECUTIVE CHAIRMAN

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,334

Underlying: Common Stock · 4,280 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: On April 18, 2023, the Reporting Person had Time-Based Restricted Stock Units (the "TBRSUs") vest in the amount of 4,280 shares of Common Stock. This issuance is pursuant to the ratable three year vesting schedule of the 12,500 TBRSU award that was granted on April 18, 2022.

F1 · derivative.expiration_date: On April 18, 2023, the Reporting Person had Time-Based Restricted Stock Units (the "TBRSUs") vest in the amount of 4,280 shares of Common Stock. This issuance is pursuant to the ratable three year vesting schedule of the 12,500 TBRSU award that was granted on April 18, 2022.

F2 · balance_after: As of the date of this filing, the remaining number of TBRSUs beneficially owned by the Reporting Person includes (a) 8,334 shares of TBRSUs granted on April 18, 2022 which are to vest ratably pursuant to their three-year vesting schedule.

SEC source: 0001415889-23-006711 · form4-04192023_040411.xml · nonDerivative · entry 1

Griffin William F Jr · CIK 0001384123 · Director · GEMMA, NON-EXECUTIVE CHAIRMAN

10b5-1 filing: No plan indicated

Ownership: Indirect · By William F Griffin Jr Revocable Trust U/A DTD FBO 12/09/04

Disclosed balance after: 174,280

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On April 18, 2023, the Reporting Person had Time-Based Restricted Stock Units (the "TBRSUs") vest in the amount of 4,280 shares of Common Stock. This issuance is pursuant to the ratable three year vesting schedule of the 12,500 TBRSU award that was granted on April 18, 2022.

SEC source: 0001415889-23-006710 · form4-04192023_040407.xml · derivative · entry 6

Deily Richard H · CIK 0001358787 · CHIEF FINANCIAL OFFICER, SVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,001

Underlying: Common Stock · 1,198 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: On April 18, 2023, the Reporting Person had TBRSUs vest in the amount of 1,198 shares of Common Stock. This issuance is pursuant to the ratable three-year vesting schedule of the 3,500 TBRSU award that was granted on April 18, 2022 and is adjusted for cash dividends.

F2 · derivative.expiration_date: On April 18, 2023, the Reporting Person had TBRSUs vest in the amount of 1,198 shares of Common Stock. This issuance is pursuant to the ratable three-year vesting schedule of the 3,500 TBRSU award that was granted on April 18, 2022 and is adjusted for cash dividends.

F7 · balance_after: As of the date of this filing, the remaining number of TBRSUs beneficially owned by the Reporting Person includes (a) 1,167 shares of TBRSUs granted on April 16, 2021; (b) 2,334 shares of TBRSUs granted on April 18, 2022; and (c) 12,500 shares of TBRSUs granted on September 13, 2022; all to vest pursuant to their respective three-year vesting schedule.

SEC source: 0001415889-23-006710 · form4-04192023_040407.xml · nonDerivative · entry 2

Deily Richard H · CIK 0001358787 · CHIEF FINANCIAL OFFICER, SVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,618

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: On April 18, 2023, the Reporting Person had TBRSUs vest in the amount of 1,198 shares of Common Stock. This issuance is pursuant to the ratable three-year vesting schedule of the 3,500 TBRSU award that was granted on April 18, 2022 and is adjusted for cash dividends.

SEC source: 0001415889-23-006709 · form4-04192023_040404.xml · derivative · entry 8

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,001

Underlying: Common Stock · 3,424 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: On April 18, 2023, the Reporting Person had TBRSUs vest in the amount of 3,424 shares of Common Stock. This issuance is pursuant to the three year vesting schedule of the 10,000 TBRSU award that was granted on April 18, 2022 and is adjusted for cash dividends.

F2 · derivative.expiration_date: On April 18, 2023, the Reporting Person had TBRSUs vest in the amount of 3,424 shares of Common Stock. This issuance is pursuant to the three year vesting schedule of the 10,000 TBRSU award that was granted on April 18, 2022 and is adjusted for cash dividends.

F10 · balance_after: As of the date of this filing, the remaining number of TBRSUs beneficially owned by the Reporting Person includes (a) 3,334 shares of TBRSUs granted on April 12, 2021; (b) 6,667 shares of TBRSUs granted on April 18, 2022; and (c) 12,000 shares of TBRSUs granted on April 17, 2023, all to vest pursuant to their respective three-year vesting schedules.

SEC source: 0001415889-23-006709 · form4-04192023_040404.xml · nonDerivative · entry 2

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,824

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: On April 18, 2023, the Reporting Person had TBRSUs vest in the amount of 3,424 shares of Common Stock. This issuance is pursuant to the three year vesting schedule of the 10,000 TBRSU award that was granted on April 18, 2022 and is adjusted for cash dividends.

SEC source: 0001415889-23-006708 · form4-04192023_040401.xml · derivative · entry 4

BOSSELMANN RAINER H · CIK 0001028546 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,501

Underlying: Common Stock · 4,280 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: On April 18, 2023, the Reporting Person had TBRSUs vest in the amount of 4,280 shares of Common Stock. This issuance is pursuant to the three year vesting schedule of the 12,500 TBRSU award that was granted on April 18, 2022 and is adjusted for cash dividends.

F2 · derivative.expiration_date: On April 18, 2023, the Reporting Person had TBRSUs vest in the amount of 4,280 shares of Common Stock. This issuance is pursuant to the three year vesting schedule of the 12,500 TBRSU award that was granted on April 18, 2022 and is adjusted for cash dividends.

F4 · balance_after: As of the date of this filing, the remaining number of TBRSUs beneficially owned by the Reporting Person includes (a) 4,167 shares of TBRSUs granted on April 16, 2021; and (b) 8,334 shares of TBRSUs granted on April 18, 2022; all to vest pursuant to their respective three year vesting schedule.

SEC source: 0001415889-23-006708 · form4-04192023_040401.xml · nonDerivative · entry 2

BOSSELMANN RAINER H · CIK 0001028546 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 399,052

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: On April 18, 2023, the Reporting Person had TBRSUs vest in the amount of 4,280 shares of Common Stock. This issuance is pursuant to the three year vesting schedule of the 12,500 TBRSU award that was granted on April 18, 2022 and is adjusted for cash dividends.

F3 · balance_after: 2,241 shares are held by Rainer and Beverley Bosselmann, as joint tenants, and the remaining shares are held directly by Rainer Bosselmann.

SEC source: 0001415889-23-006753 · form4-04202023_040401.xml · derivative · entry 9

Collins Charles Edwin IV · CIK 0001791800 · CHIEF EXECUTIVE OFFICER, GEMMA

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,334

Underlying: Common Stock · 3,424 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: On April 18, 2023, the Reporting Person had TBRSUs vest in the amount of 3,424 shares of Common Stock. This issuance is pursuant to the 10,000 TBRSU award that was granted on April 18, 2022 and is adjusted for cash dividends.

F2 · derivative.expiration_date: On April 18, 2023, the Reporting Person had TBRSUs vest in the amount of 3,424 shares of Common Stock. This issuance is pursuant to the 10,000 TBRSU award that was granted on April 18, 2022 and is adjusted for cash dividends.

F12 · balance_after: As of the date of this filing, the total number of TBRSUs owned by the reporting person include (a) 1,667 shares of TBRSUs granted on April 16, 2021; (b) 6,667 shares of TBRSUs granted on April 18, 2022; and (c) 5,000 shares of TBRSUs granted on April 17, 2023; all to vest according to their respective three-year vesting schedule.

SEC source: 0001415889-23-006753 · form4-04202023_040401.xml · nonDerivative · entry 2

Collins Charles Edwin IV · CIK 0001791800 · CHIEF EXECUTIVE OFFICER, GEMMA

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,882

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: On April 18, 2023, the Reporting Person had TBRSUs vest in the amount of 3,424 shares of Common Stock. This issuance is pursuant to the 10,000 TBRSU award that was granted on April 18, 2022 and is adjusted for cash dividends.

SEC source: 0001415889-23-006710 · form4-04192023_040407.xml · derivative · entry 5

Deily Richard H · CIK 0001358787 · CHIEF FINANCIAL OFFICER, SVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,500

Underlying: Common Stock · 2,500 shares

Expires not disclosed

F6 · derivative.exercise_date: On April 17, 2023, the Reporting Person was granted Earnings Per Share Performance-Based Restricted Stock Units ("EPSRSUs") in the target number of 2,500 shares, the vesting of which is subject to the sum of Earnings Per Share ("EPS") for fiscal years ending January 31, 2024, 2025 and 2026 compared to target compounded growth EPS amounts based on the sum of EPS for the fiscal years ended January 31, 2021, 2022 and 2023. The pay-out ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievenent of the EPS ranking at the end of the three-year performance period. The awards will be more fully described in the Issuer's 2023 Proxy Statement. Each EPSRSU represents a contingent right to achieve one share of the Issuer's common stock.

F6 · derivative.expiration_date: On April 17, 2023, the Reporting Person was granted Earnings Per Share Performance-Based Restricted Stock Units ("EPSRSUs") in the target number of 2,500 shares, the vesting of which is subject to the sum of Earnings Per Share ("EPS") for fiscal years ending January 31, 2024, 2025 and 2026 compared to target compounded growth EPS amounts based on the sum of EPS for the fiscal years ended January 31, 2021, 2022 and 2023. The pay-out ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievenent of the EPS ranking at the end of the three-year performance period. The awards will be more fully described in the Issuer's 2023 Proxy Statement. Each EPSRSU represents a contingent right to achieve one share of the Issuer's common stock.

SEC source: 0001415889-23-006710 · form4-04192023_040407.xml · derivative · entry 4

Deily Richard H · CIK 0001358787 · CHIEF FINANCIAL OFFICER, SVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,500

Underlying: Common Stock · 2,500 shares

Expires 2033-04-17

F3 · shares: On April 17, 2023, the Reporting Person received 10-year options to purchase 2,500 shares of the Issuer's common stock with an exercise price of $39.47 per share. The options will vest ratably over three years on each anniversary of the grant date starting from 4/17/2024.

F4 · balance_after: As of the date of this Filing, the total number of options owned by the Reporting Person includes (a) options acquire 10,000 shares of common stock at the price of $33.85 per share with a Date Exercisable of 04/13/2017 and Expiration Date of 04/13/2026; (b) options to acquire 10,000 shares of common stock at a price of $64.25 per share with Date Exercisable of 04/06/2018 and Expiration Date of 04/06/2027; (c) options to acquire 10,000 shares of common stock at a price of $37.60 per share with Date Exercisable of 04/13/2019 and Expiration Date of 04/13/2028; (d) options to acquire 10,000 shares of common stock at a price of $50.30 per share with Date Exercisable of 4/12/2020 and Expiration Date of 4/12/2029;

F5 · balance_after: (e) options to acquire 10,000 shares of common stock at a price of $33.81 per share with a Date Exercisable of 4/16/2021 and Expiration Date of 4/16/2030; (f) options to acquire 3,500 shares of common stock at a price of $54.60 per share with a Date Exercisable of 4/16/2022 and Expiration Date of 4/16/2031; (g) options to acquire 3,500 shares of common stock at a price of $36.78 per share with a Date Exercisable of 4/18/2023 and Expiration Date of 4/18/2032; and (h) options to acquire 2,500 shares of common stock at a price of $39.47 with a Date Exercisable of 4/17/2024 and Expiration Date of 4/17/2033. Options identified in subjects (c), (d), (e), (f), (g) and (h) are subject to the three-year ratable vesting schedule described in Footnote 3.

SEC source: 0001415889-23-006709 · form4-04192023_040404.xml · derivative · entry 7

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires not disclosed

F9 · derivative.exercise_date: On April 17, 2023, the Reporting Person was granted Earnings Per Share Performance-Based Restricted Stock Units ("EPSRSUs") in the target number of 10,000 shares, the vesting of which is subject to the sum of Earnings Per Share ("EPS") for fiscal years ending January 31, 2024, 2025 and 2026 compared to target compounded growth EPS amounts based on the sum of EPS for the fiscal years ended January 31, 2021, 2022 and 2023. The pay-out ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievenent of the EPS ranking at the end of the three-year performance period. The awards will be more fully described in the Issuer's 2023 Proxy Statement. Each EPSRSU represents a contingent right to achieve one share of the Issuer's common stock.

F9 · derivative.expiration_date: On April 17, 2023, the Reporting Person was granted Earnings Per Share Performance-Based Restricted Stock Units ("EPSRSUs") in the target number of 10,000 shares, the vesting of which is subject to the sum of Earnings Per Share ("EPS") for fiscal years ending January 31, 2024, 2025 and 2026 compared to target compounded growth EPS amounts based on the sum of EPS for the fiscal years ended January 31, 2021, 2022 and 2023. The pay-out ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievenent of the EPS ranking at the end of the three-year performance period. The awards will be more fully described in the Issuer's 2023 Proxy Statement. Each EPSRSU represents a contingent right to achieve one share of the Issuer's common stock.

SEC source: 0001415889-23-006709 · form4-04192023_040404.xml · derivative · entry 6

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 5,000 shares

Expires not disclosed

F7 · derivative.exercise_date: On April 17, 2023, the Reporting Person was granted Performance-Based Restricted Stock Units (the "PBRSUs") in the target number of 5,000 shares (the "Target"), the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2023 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.

F7 · derivative.expiration_date: On April 17, 2023, the Reporting Person was granted Performance-Based Restricted Stock Units (the "PBRSUs") in the target number of 5,000 shares (the "Target"), the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2023 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.

F8 · balance_after: As of the date of this filing, the remaining number of PBRSUs beneficially owned by the Reporting Person includes (a) a target number of 10,000 shares of PBRSUs granted on April 16, 2021; (b) a target number of 10,000 shares of PBRSUs granted on April 18, 2022; and (c) a target number of 5,000 shares of PBRSUs grated on April 17, 2023; all to vest in their entirety at the end of their respective three-year performance period.

SEC source: 0001415889-23-006709 · form4-04192023_040404.xml · derivative · entry 5

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,334

Underlying: Common Stock · 12,000 shares

Expires not disclosed

F6 · derivative.exercise_date: On April 17, 2023, the Reporting Person was granted TBRSUs covering 12,000 shares of common stock. The TBRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 04/17/2024.

F6 · derivative.expiration_date: On April 17, 2023, the Reporting Person was granted TBRSUs covering 12,000 shares of common stock. The TBRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 04/17/2024.

SEC source: 0001415889-23-006709 · form4-04192023_040404.xml · derivative · entry 4

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 191,000

Underlying: Common Stock · 5,000 shares

Expires 2033-04-17

F3 · shares: On April 17, 2023, the Reporting Person received 10-year options to purchase 5,000 shares of the Issuer's common stock with an exercise price of $39.47 per share. The options will vest ratably over three years on each anniversary of the grant date starting from 04/17/2024.

F4 · balance_after: As of the date of this filing, the total number of options owned by the Reporting Person includes (a) options to acquire 30,000 shares of common stock at a price of $41.68 with Date Exercisable of 6/23/2017 and Expiration Date of 6/23/2026; (b) options to acquire 40,000 shares of common stock at a price of $64.25 per share with Date Exercisable of 4/06/2018 and Expiration Date of 4/06/2027; (c) options to acquire 32,000 shares of common stock at a price of $37.60 per share with Date Exercisable of 4/13/2019 and Expiration Date of 4/13/2028; (d) options to acquire 32,000 shares of common stock at a price of $50.30 with a Date Exercisable of 4/12/2020 and Expiration date of 4/12/2029;

F5 · balance_after: (e) options to acquire 32,000 shares of common stock at a price of $33.81 with a Date Exercisable of 4/16/2021 and Expiration Date of 4/16/2030; (f) options to acquire 10,000 shares of common stock at a price of $54.60 with a Date Exercisable of 4/16/2022 and Expiration Date of 4/16/2031; (g) options to acquire 10,000 shares of common stock at a price of $36.78 per share with Date Exercisable 4/18/2023 and Expiration Date of 4/18/2032; and (h) options to acquire 5,000 shares of common stock at a price of $39.47 per share with Date Exercisable of 4/17/2024 and Expiration Date of 4/17/2033; all subject to the three-year ratable vesting schedule described in footnote 3.

SEC source: 0001415889-23-006753 · form4-04202023_040401.xml · derivative · entry 8

Collins Charles Edwin IV · CIK 0001791800 · CHIEF EXECUTIVE OFFICER, GEMMA

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,500

Underlying: Common Stock · 2,500 shares

Expires not disclosed

F11 · derivative.exercise_date: On April 17, 2023, the Reporting Person was granted Earnings Per Share Performance-Based Restricted Stock Units ("EPSRSUs") in the target number of 2,500 shares, the vesting of which is subject to the sum of Earnings Per Share ("EPS") for fiscal years ending January 31, 2024, 2025 and 2026 compared to target compounded growth EPS amounts based on the sum of EPS for the fiscal years ended January 31, 2021, 2022 and 2023. The pay-out ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievenent of the EPS ranking at the end of the three-year performance period.

F11 · derivative.expiration_date: On April 17, 2023, the Reporting Person was granted Earnings Per Share Performance-Based Restricted Stock Units ("EPSRSUs") in the target number of 2,500 shares, the vesting of which is subject to the sum of Earnings Per Share ("EPS") for fiscal years ending January 31, 2024, 2025 and 2026 compared to target compounded growth EPS amounts based on the sum of EPS for the fiscal years ended January 31, 2021, 2022 and 2023. The pay-out ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievenent of the EPS ranking at the end of the three-year performance period.

SEC source: 0001415889-23-006753 · form4-04202023_040401.xml · derivative · entry 7

Collins Charles Edwin IV · CIK 0001791800 · CHIEF EXECUTIVE OFFICER, GEMMA

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,500

Underlying: Common Stock · 7,500 shares

Expires not disclosed

F9 · derivative.exercise_date: On April 17, 2023 the Reporting Person was granted Renewable Performance-Based Restricted Stock Units (the "RRSUs") in the target number of 7,500 shares, the vesting of which is subject to Gemma Power Systems, LLC and its affiliates obtaining new renewable energy projects with an aggregate contract value exceeding certain identified hurdle amounts for each of the performance periods. The four performance periods cover three consecutive one-year periods each with a target number of 1,500 shares and a cumulative total at the end of the three-year performance period with a target number of 3,000 shares. The awards will be more fully described in the Issuer's 2023 Proxy Statement. Each RRSU represents a contingent right to receive one share of the Issuer's common stock.

F9 · derivative.expiration_date: On April 17, 2023 the Reporting Person was granted Renewable Performance-Based Restricted Stock Units (the "RRSUs") in the target number of 7,500 shares, the vesting of which is subject to Gemma Power Systems, LLC and its affiliates obtaining new renewable energy projects with an aggregate contract value exceeding certain identified hurdle amounts for each of the performance periods. The four performance periods cover three consecutive one-year periods each with a target number of 1,500 shares and a cumulative total at the end of the three-year performance period with a target number of 3,000 shares. The awards will be more fully described in the Issuer's 2023 Proxy Statement. Each RRSU represents a contingent right to receive one share of the Issuer's common stock.

F10 · balance_after: As of the date of this filing, the total number of RRSUs owned by the reporting person include (a) a remaining number of 3,000 shares of RRSUs granted on April 16, 2021; (b) a remaining number of 6,000 shares of RRSUs granted on April 18, 2022; and (c) a target number of 7,500 shares of RRSUs granted on April 17, 2023; all to vest according to their respective three-year performance schedule.

SEC source: 0001415889-23-006753 · form4-04202023_040401.xml · derivative · entry 6

Collins Charles Edwin IV · CIK 0001791800 · CHIEF EXECUTIVE OFFICER, GEMMA

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,000

Underlying: Common Stock · 1,000 shares

Expires not disclosed

F7 · derivative.exercise_date: On April 17, 2023, the Reporting Person was granted Performance-Based Restricted Stock Units (the "PBRSUs") in the target number of 1,000 shares (the "Target"), the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2023 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.

F7 · derivative.expiration_date: On April 17, 2023, the Reporting Person was granted Performance-Based Restricted Stock Units (the "PBRSUs") in the target number of 1,000 shares (the "Target"), the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2023 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.

F8 · balance_after: As of the date of this filing, the total number of PBRSUs owned by the Reporting Person includes (a) a target number of 1,000 shares of PBRSUs granted on April 16, 2021; (b) a target number of 1,000 shares of PBRSUs granted on April 18, 2022; and (c) a target number of 1,000 shares of PBRSUs granted on April 17, 2023; all to vest according to their respective three-year performance period.

SEC source: 0001415889-23-006753 · form4-04202023_040401.xml · derivative · entry 5

Collins Charles Edwin IV · CIK 0001791800 · CHIEF EXECUTIVE OFFICER, GEMMA

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,667

Underlying: Common Stock · 5,000 shares

Expires not disclosed

F6 · derivative.exercise_date: On April 17, 2023, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 5,000 shares of common stock. The TBRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 04/17/2024.

F6 · derivative.expiration_date: On April 17, 2023, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 5,000 shares of common stock. The TBRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 04/17/2024.

SEC source: 0001415889-23-006753 · form4-04202023_040401.xml · derivative · entry 4

Collins Charles Edwin IV · CIK 0001791800 · CHIEF EXECUTIVE OFFICER, GEMMA

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,500

Underlying: Common Stock · 2,500 shares

Expires 2033-04-17

F3 · shares: On April 17, 2023, the Reporting Person received 10-year options to purchase 2,500 shares of the Issuer's common stock with an exercise price of $39.47 per share. The options will vest ratably over three years on each anniversary of the grant date starting from 4/17/2024.

F4 · balance_after: As of the date of this filing, the total number of options owned by the Reporting Person includes (a) options to acquire 5,000 shares of common stock at a price of $46.35 with Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; (b) options to acquire 25,000 shares of common stock at a price of $43.10 with Date Exercisable of 9/12/2019 and Expiration Date of 9/12/2028; (c) options to acquire 10,000 shares of common stock at a price of $42.31 with Date Exercisable of 9/10/2020 and Expiration Date of 9/10/2029; (d) options to acquire 10,000 shares of common stock at a price of $33.81 with Date Exercisable on 4/16/2021 and Expiration Date 4/16/2030; (e) options to acquire 5,000 shares of common stock at a price of $36.78 with Date Exercisable of 4/18/2023 and Expiration Date of 4/18/2032;

F5 · balance_after: and (f) options to acquire 2,500 shares of common stock at a price of $39.47 with Date Exercisable of 4/17/2024 and Expiration Date of 4/17/2033; all of which will vest ratably over three years on the anniversary of their respective grant date.

SEC source: 0001415889-23-006710 · form4-04192023_040407.xml · derivative · entry 3

Deily Richard H · CIK 0001358787 · CHIEF FINANCIAL OFFICER, SVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,167

Underlying: Common Stock · 1,227 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: On April 16, 2023, the Reporting Person had Time-Based Restricted Stock Units (the "TBRSUs") vest in the amount of 1,227 shares of Common Stock. This issuance is pursuant to the ratable three year vesting schedule of the 3,500 TBRSU award that was granted on April 16, 2021 and is adjusted for cash dividends.

F1 · derivative.expiration_date: On April 16, 2023, the Reporting Person had Time-Based Restricted Stock Units (the "TBRSUs") vest in the amount of 1,227 shares of Common Stock. This issuance is pursuant to the ratable three year vesting schedule of the 3,500 TBRSU award that was granted on April 16, 2021 and is adjusted for cash dividends.

SEC source: 0001415889-23-006710 · form4-04192023_040407.xml · nonDerivative · entry 1

Deily Richard H · CIK 0001358787 · CHIEF FINANCIAL OFFICER, SVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,420

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On April 16, 2023, the Reporting Person had Time-Based Restricted Stock Units (the "TBRSUs") vest in the amount of 1,227 shares of Common Stock. This issuance is pursuant to the ratable three year vesting schedule of the 3,500 TBRSU award that was granted on April 16, 2021 and is adjusted for cash dividends.

SEC source: 0001415889-23-006709 · form4-04192023_040404.xml · derivative · entry 3

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,334

Underlying: Common Stock · 3,505 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: On April 16, 2023, the Reporting Person had Time-Based Restricted Stock Units (the "TBRSUs") vest in the amount of 3,505 shares of Common Stock. This issuance is pursuant to the three year vesting schedule of the 10,000 TBRSU award that was granted on April 16, 2021 and is adjusted for cash dividends.

F1 · derivative.expiration_date: On April 16, 2023, the Reporting Person had Time-Based Restricted Stock Units (the "TBRSUs") vest in the amount of 3,505 shares of Common Stock. This issuance is pursuant to the three year vesting schedule of the 10,000 TBRSU award that was granted on April 16, 2021 and is adjusted for cash dividends.

SEC source: 0001415889-23-006709 · form4-04192023_040404.xml · nonDerivative · entry 1

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,400

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On April 16, 2023, the Reporting Person had Time-Based Restricted Stock Units (the "TBRSUs") vest in the amount of 3,505 shares of Common Stock. This issuance is pursuant to the three year vesting schedule of the 10,000 TBRSU award that was granted on April 16, 2021 and is adjusted for cash dividends.

SEC source: 0001415889-23-006708 · form4-04192023_040401.xml · derivative · entry 3

BOSSELMANN RAINER H · CIK 0001028546 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,667

Underlying: Common Stock · 4,382 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: On April 16, 2023, the Reporting Person had Time-Based Restricted Stock Units ("the TBRSUs") vest in the amount of 4,382 shares of Common Stock. This issuance is pursuant to the three year vesting schedule of the 12,500 TBRSU award that was granted on April 16, 2021 and is adjusted for cash dividends.

F1 · derivative.expiration_date: On April 16, 2023, the Reporting Person had Time-Based Restricted Stock Units ("the TBRSUs") vest in the amount of 4,382 shares of Common Stock. This issuance is pursuant to the three year vesting schedule of the 12,500 TBRSU award that was granted on April 16, 2021 and is adjusted for cash dividends.

SEC source: 0001415889-23-006708 · form4-04192023_040401.xml · nonDerivative · entry 1

BOSSELMANN RAINER H · CIK 0001028546 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 394,772

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On April 16, 2023, the Reporting Person had Time-Based Restricted Stock Units ("the TBRSUs") vest in the amount of 4,382 shares of Common Stock. This issuance is pursuant to the three year vesting schedule of the 12,500 TBRSU award that was granted on April 16, 2021 and is adjusted for cash dividends.

SEC source: 0001415889-23-006753 · form4-04202023_040401.xml · derivative · entry 3

Collins Charles Edwin IV · CIK 0001791800 · CHIEF EXECUTIVE OFFICER, GEMMA

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,667

Underlying: Common Stock · 1,753 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: On April 16, 2023, the Reporting Person had Time-Based Restricted Stock Units (the "TBRSUs') vest in the amount of 1,753 shares of Common Stock. This issuance is pursuant to the 5,000 TBRSU award that was granted on April 16, 2021 and is adjusted for cash dividends.

F1 · derivative.expiration_date: On April 16, 2023, the Reporting Person had Time-Based Restricted Stock Units (the "TBRSUs') vest in the amount of 1,753 shares of Common Stock. This issuance is pursuant to the 5,000 TBRSU award that was granted on April 16, 2021 and is adjusted for cash dividends.

SEC source: 0001415889-23-006753 · form4-04202023_040401.xml · nonDerivative · entry 1

Collins Charles Edwin IV · CIK 0001791800 · CHIEF EXECUTIVE OFFICER, GEMMA

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,458

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On April 16, 2023, the Reporting Person had Time-Based Restricted Stock Units (the "TBRSUs') vest in the amount of 1,753 shares of Common Stock. This issuance is pursuant to the 5,000 TBRSU award that was granted on April 16, 2021 and is adjusted for cash dividends.

SEC source: 0001415889-23-004489 · form4-03082023_040304.xml · derivative · entry 2

QUINN JAMES W · CIK 0001094454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,000

Underlying: Common Stock · 5,000 shares

Expires 2023-12-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-23-004489 · form4-03082023_040304.xml · nonDerivative · entry 1

QUINN JAMES W · CIK 0001094454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,570

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On March 7, 2023 the Reporting Person exercised a portion of his stock option received on December 17, 2013 and purchased 5,000 shares of the Issuer's common stock at a price of $26.88 per share.

SEC source: 0001415889-23-004488 · form4-03082023_040301.xml · derivative · entry 2

BOSSELMANN RAINER H · CIK 0001028546 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 295,000

Underlying: Common Stock · 25,000 shares

Expires 2023-03-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-23-004488 · form4-03082023_040301.xml · nonDerivative · entry 1

BOSSELMANN RAINER H · CIK 0001028546 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 390,390

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On March 6, 2023 the Reporting Person exercised his stock option received on March 7, 2013 to purchase 25,000 shares of the Issuer's common stock at a price of $16.37 per share.

F2 · balance_after: 2,241 shares are held by Rainer and Beverley Bosselmann, as joint tenants, and the remaining shares are held directly by Rainer Bosselmann.

SEC source: 0001415889-22-012850 · form4-12202022_041234.xml · derivative · entry 2

Leimkuhler William F. · CIK 0001361943 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,500

Underlying: Common Stock · 1,750 shares

Expires 2025-12-16

F4 · shares: On December 16, 2022, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 1,750 shares of common stock. The TBRSUs will vest in their entirety on the third anniversary of the grant date on 12/16/2025.

F5 · balance_after: (g) 10,000 shares of common stock at a price of $40.15 with initial Date Exercisable of 12/23/2020 and an Expiration Date of 12/23/2029; (h) 10,000 shares of common stock at a price of $45.75 per share with initial Date Exercisable of 12/14/2021 and Expiration Date of 12/14/2030; (i) 5,000 shares of common stock at a price of $37.13 per share with initial Date Exercisable of 12/14/2022 and Expiration Date of 12/14/203; and (j) 5,000 shares of common stock at a price of $35.72 per share with initial Date Exercisable of 12/16/2023 and Expiration Date of 12/16/2032. All stock options are subject to the aforementioned three-year ratable vesting schedule except those awarded prior to January 2018 which vested fully on the first anniversary of the date of award.

SEC source: 0001415889-22-012850 · form4-12202022_041234.xml · derivative · entry 1

Leimkuhler William F. · CIK 0001361943 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,000

Underlying: Common Stock · 5,000 shares

Expires 2032-12-16

F1 · shares: On December 16, 2022, the Reporting Person received 10-year options to purchase 5,000 shares of the Issuer's Common Stock at an exercise price of $35.72 per share. The options will vest ratably over three years on each anniversary of the grant date beginning on 12/16/2023.

F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 10,000 shares of Common Stock at a price of $26.88 per share with initial Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (b) 10,000 shares of Common Stock at a price of $31.82 per share with initial Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (c) 10,000 shares of Common Stock at a price of $30.44 per share with initial Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026; (d) 10,000 shares of common stock at a price of $71.75 per share with initial Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; (e) 10,000 shares of common stock at a price of $46.35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; (f) 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable of 12/12/2019 and Expiration Date of 12/12/2028;

F3 · balance_after: (g) 10,000 shares of common stock at a price of $40.15 with initial Date Exercisable of 12/23/2020 and an Expiration Date of 12/23/2029; (h) 10,000 shares of common stock at a price of $45.75 per share with initial Date Exercisable of 12/14/2021 and Expiration Date of 12/14/2030; (i) 5,000 shares of common stock at a price of $37.13 per share with initial Date Exercisable of 12/14/2022 and Expiration Date of 12/14/203; and (j) 5,000 shares of common stock at a price of $35.72 per share with initial Date Exercisable of 12/16/2023 and Expiration Date of 12/16/2032. All stock options are subject to the aforementioned three-year ratable vesting schedule except those awarded prior to January 2018 which vested fully on the first anniversary of the date of award.

SEC source: 0001415889-22-012851 · form4-12202022_041240.xml · derivative · entry 2

Getsinger Peter W · CIK 0001627519 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,500

Underlying: Common Stock · 1,750 shares

Expires 2025-12-16

F4 · shares: On December 16, 2022, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 1,750 shares of common stock. The TBRSUs will vest in their entirety on the third anniversary of the grant date on 12/16/2025.

F5 · balance_after: As of the date of this filing, the total number of TBRSUs beneficially owned by the Reporting P erson includes (a) 1,750 shares of TBRSUs granted on December 14, 2021 and (b) 1,750 shares of TBRSUs granted on December 16, 2022. All are to vest in their entirety on the third anniversary of their respective grant date.

SEC source: 0001415889-22-012851 · form4-12202022_041240.xml · derivative · entry 1

Getsinger Peter W · CIK 0001627519 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,000

Underlying: Common Stock · 5,000 shares

Expires 2032-12-16

F1 · shares: On December 16, 2022, the Reporting Person received 10-year options to purchase 5,000 shares of the Issuer's Common Stock at an exercise price of $35.72 per share. The options will vest ratably over three years on each anniversary of the grant date beginning on 12/16/2023.

F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 7,000 shares of common stock at a price of $30.44 per share with initial Date Exercisable of 01/07/2017 and Expiration Date of 01/07/2026; (b) 10,000 shares of common stock at a price of $71.75 per share with initial Date Exercisable of 01/05/2018 and Expiration Date of 01/05/2027; (c) 10,000 shares of common stock at a price of $46 35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; (d) 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable on 12/12/2019 and Expiration Date of 12/12/2028; (e) 10,000 shares of common stock at a price of $40.15 per share with initial Date Exercisable on 12/23/2020 and Expiration Date of 12/23/2029; (f) 10,000 shares of common stock at a price of $45.75 per share with initial Date Exercisable of 12/14/2021 and Expiration Date of 12/14/2030;

F3 · balance_after: (g) 5,000 shares of common stock at a price of $37.13 per share with initial Date Exercisable of 12/14/2022 and Expiration Date of 12/14/2031; and (h) 5,000 shares of common stock at a price of $35.72 per share with initial Date Exercisable of 12/16/2023 and Expiration Date of 12/16/2032. All stock options are subject to the aforementioned three-year ratable vesting schedule except those awarded prior to January 2018 which vested fully on the first anniversary of the date of award.

SEC source: 0001415889-22-012849 · form4-12202022_041225.xml · derivative · entry 2

Jeffrey John Ronald Jr. · CIK 0001709914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,500

Underlying: Common Stock · 1,750 shares

Expires 2025-12-16

F4 · shares: On December 16, 2022, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 1,750 shares of common stock. The TBRSUs will vest in their entirety on the third anniversary of the grant date on 12/16/2025.

F5 · balance_after: As of the date of this filing, the total number of TBRSUs beneficially owned by the Reporting Person includes (a) 1,750 shares of TBRSUs granted on December 14, 2021 and (b) 1,750 shares of TBRSUs granted on December 16, 2022. All are to vest in their entirety on the third anniversary of their respective grant date.

SEC source: 0001415889-22-012849 · form4-12202022_041225.xml · derivative · entry 1

Jeffrey John Ronald Jr. · CIK 0001709914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 5,000 shares

Expires 2032-12-16

F1 · shares: On December 16, 2022, the Reporting Person received 10-year options to purchase 5,000 shares of the Issuer's Common Stock at an exercise price of $35.72 per share. The options will vest ratably over three years on each anniversary of the grant date beginning on 12/16/2023

F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 10,000 shares of common stock at a price of $60.05 per share with initial Date Exercisable of 06/22/2018 and Expiration Date of 06/22/2027; (b) 10,000 shares of common stock at a price of $46 35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; (c) 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable of 12/12/2019 and Expiration Date of 12/12/2028; (d) 10,000 shares of common stock at a price of $40.15 per share with initial Date Exercisable of 12/23/2020 and Expiration Date of 12/23/2029; (e) 10,000 shares of common stock at a price of $45.75 per share with initial Date Exercisable 12/14/2021 and Expiration Date of 12/14/2030; (f) 5,000 shares of common stock at a price of $37.13 per share with initial Date Exercisable of 12/14/2022 and Expiration Date of 12/14/2031; and

F3 · balance_after: (g) 5,000 shares of common stock at a price of $35.72 per share with initial Date Exercisable of 12/16/2023 and Expiration Date of 12/16/2032. All stock options are subject to the aforementioned three-year ratable vesting schedule except those awarded prior to January 2018 which vested fully on the first anniversary of the date of award.

SEC source: 0001415889-22-012848 · form4-12202022_041217.xml · derivative · entry 2

MITCHELL W G CHAMPION · CIK 0001204823 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,500

Underlying: Common Stock · 1,750 shares

Expires 2025-12-16

F4 · shares: On December 16, 2022, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 1,750 shares of common stock. The TBRSUs will vest in their entirety on the third anniversary of the grant date on 12/16/2025.

F5 · balance_after: As of the date of this filing, the total number of TBRSUs beneficially owned by the Reporting Person includes (a) 1,750 shares of TBRSUs granted on December 14, 2021 and (b) 1,750 shares of TBRSUs granted on December 16, 2022. All are to vest in their entirety on the third anniversary of their respective grant date.

SEC source: 0001415889-22-012848 · form4-12202022_041217.xml · derivative · entry 1

MITCHELL W G CHAMPION · CIK 0001204823 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,667

Underlying: Common Stock · 5,000 shares

Expires 2032-12-16

F1 · shares: On December 16, 2022, the Reporting Person received 10-year options to purchase 5,000 shares of the Issuer's Common Stock at an exercise price of $35.72 per share. The options will vest ratably over three years on each anniversary of the grant date beginning on 12/16/2023.

F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 10,000 shares of common stock at a price of $71.75 per share with initial Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; (b) 6,667 shares of common stock at a price of $46.35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; (c) 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable on 12/12/2019 and Expiration Date of 12/12/2028; (d) 10,000 shares of common stock at a price of $40.15 per share with an initial Date Exercisable of 12/23/2020 and Expiration Date of 12/23/2029; (e) 10,000 shares of common stock at a price of $45.75 per share with initial Date Exercisable of 12/14/2021 and Expiration Date of 12/14/2030; (f) 5,000 shares of common stock at a price of $37.13 per share with initial Date Exercisable of 12/14/2022 and Expiration Date of 12/14/2031; and

F3 · balance_after: (g) 5,000 shares of common stock at a price of $35.72 per share with an initial Date Exercisable of 12/16/2023 and Expiration Date of 12/16/2032. All stock options are subject to the aforementioned three-year ratable vesting schedule except those awarded prior to January 2018 which vested fully on the first anniversary of the date of award.

SEC source: 0001415889-22-012846 · form4-12202022_041206.xml · derivative · entry 2

Koilpillai Mano S · CIK 0001790160 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,500

Underlying: Common Stock · 1,750 shares

Expires 2025-12-16

F3 · shares: On December 16, 2022, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 1,750 shares of common stock. The TBRSUs will vest in their entirety on the third anniversary of the grant date on 12/16/2025.

F4 · balance_after: As of the date of this filing, the total number of TBRSUs beneficially owned by the Reporting Person includes (a) 1,750 shares of TBRSUs granted on December 14, 2021 and (b) 1,750 shares of TBRSUs granted on December 16, 2022. All are to vest in their entirety on the third anniversary of their respective grant date.

SEC source: 0001415889-22-012846 · form4-12202022_041206.xml · derivative · entry 1

Koilpillai Mano S · CIK 0001790160 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,667

Underlying: Common Stock · 5,000 shares

Expires 2032-12-16

F1 · shares: On December 16, 2022, the Reporting Person received 10-year options to purchase 5,000 shares of the Issuer's Common Stock at an exercise price of $35.72 per share. The options will vest ratably over three years on each anniversary of the grant date beginning on 12/16/2023.

F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 10,000 shares of common stock at a price of $42.31 per share with initial Date Exercisable of 9/10/2020 and Expiration Date of 9/10/2029; (b) 6,667 shares of common stock at a price of $40.15 per share with initial Date Exercisable of 12/23/2020 and Expiration Date of 12/23/2029; (c) 10,000 shares of common stock at a price of $45.75 per share with initial Date Exercisable of 12/14/2021 and Expiration Date of 12/14/2030; (d) 5,000 shares of common stock at a price of $37.13 per share with an initial Date Exercisable of 12/14/2022 and Expiration Date of 12/14/2031; and (e) 5,000 shares of common stock at a price of $35.72 per share with an initial Date Exercisable of 12/16/2023 and Expiration date of 12/16/2032; all of which vest ratably over three years on the anniversary of each grant date.

SEC source: 0001415889-22-012847 · form4-12202022_041212.xml · derivative · entry 2

QUINN JAMES W · CIK 0001094454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,500

Underlying: Common Stock · 1,750 shares

Expires 2025-12-16

F4 · shares: On December 16, 2022, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 1,750 shares of common stock. The TBRSUs will vest in their entirety on the third anniversary of their grant date on 12/16/2025.

F5 · balance_after: As of the date of this filing, the total number of TBRSUs beneficially owned by the Reporting Person includes (a) 1,750 shares of TBRSUs granted on December 14, 2021 and (b) 1,750 shares of TBRSUs granted on December 16, 2022. All are to vest in their entirety on the third anniversary of their respective grant date.

SEC source: 0001415889-22-012847 · form4-12202022_041212.xml · derivative · entry 1

QUINN JAMES W · CIK 0001094454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,000

Underlying: Common Stock · 5,000 shares

Expires 2032-12-16

F1 · shares: On December 16, 2022, the Reporting Person received 10-year options to purchase 5,000 shares of the Issuer's Common Stock at an exercise price of $35.72 per share. The options will vest ratably over three years on each anniversary of the grant date beginning on 12/16/2023.

F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 10,000 shares of common stock at a price of $26.88 with initial Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (b) 10,000 shares of common stock at a price of $31.82 per share with initial Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (c) 10,000 shares of common stock at a price of $30.44 per share with initial Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026; (d) 10,000 shares of common stock at a price of $71.75 per share with initial Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; (e) 10,000 shares of common stock at a price of $46.35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; (f) 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable of 12/12/2019 and Expiration Date of 12/12/2028;

F3 · balance_after: (g) 10,000 shares of common stock at a price of $40.15 per share with initial Date Exercisable of 12/23/2020 and Expiration Date of 12/23/2029; (h) 10,000 shares of common stock at a price of $45.75 per share with initial Date Exercisable of 12/14/2021 and Expiration Date of 12/14/2030; (i) 5,000 shares of common stock at a price of $37.13 per share with initial Date Exercisable of 12/14/2022 and Expiration Date of 12/14/2031; and (j) 5,000 shares of common stock at a price of $35.72 per share with initial Date Exercisable of 12/16/2023 and Expiration Date of 12/16/2032. All stock options are subject to the aforementioned three year ratable vesting schedule except those awarded prior to January 2018 which vested fully on the first anniversary of the date of award.

SEC source: 0001415889-22-012845 · form4-12202022_041201.xml · derivative · entry 2

Flanders Cynthia · CIK 0001463638 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,500

Underlying: Common Stock · 1,750 shares

Expires 2025-12-16

F4 · shares: On December 16, 2022, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 1,750 shares of common stock. The TBRSUs will vest in their entirety on the third anniversary of the grant date on 12/16/2025.

F5 · balance_after: As of the date of this filing, the total number of TBRSUs owned by the the Reporting Person includes (a) 1,750 shares TBRSUs granted on December 14, 2021 and (b) 1,750 shares of TBRSUs granted on December 16, 2022. All are to vest in their entirety on the third anniversary of their respective grant date.

SEC source: 0001415889-22-012845 · form4-12202022_041201.xml · derivative · entry 1

Flanders Cynthia · CIK 0001463638 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,000

Underlying: Common Stock · 5,000 shares

Expires 2032-12-16

F1 · shares: On December 16, 2022, the Reporting Person received 10-year options to purchase 5,000 shares of the Issuer's common stock with an exercise price of $35.72 per share. The options will vest ratably over three years on each anniversary of the grant date starting from 12/16/2023.

F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 7,000 shares of common stock at a price of $26.88 per share with initial Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (b) 10,000 shares of common stock at a price of $31.82 per share with initial Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (c) 10,000 shares of common stock at a price of $30.44 per share with initial Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026; d) 10,000 shares of common stock at a price of $71.75 per share with initial Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; (e) 10,000 shares of common stock at a price of $46.35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; (f) 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable of 12/12/2019 and Expiration Date of 12/12/2028;

F3 · balance_after: (g) 10,000 shares of common stock at a price of $40.15 per share with initial Date Exercisable of 12/23/2020 and Expiration Date of 12/23/2029; (h) 10,000 shares of common stock at a price of $45.75 per share with initial Date Exercisable of 12/14/2021 and Expiration Date of 12/14/2030; (i) 5,000 shares of common stock at a price of $37.13 per share with initial Date Exercisable of 12/14/2022 and Expiration Date of 12/14/2031; and (j) 5,000 shares of common stock at a price of 35.72 per share with initial Date Exercisable of 12/16/2023 and Expiration Date of 12/16/2032. All stock options are subject to the aforementioned three-year ratable vesting schedule except those awarded prior to January 2018 which vested fully on the first anniversary of the date of award.

SEC source: 0001415889-22-009611 · form4-09142022_010946.xml · derivative · entry 2

Deily Richard H · CIK 0001358787 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,500

Underlying: Common Stock · 2,500 shares

Expires not disclosed

F3 · derivative.exercise_date: On September 13, 2022, the Reporting Person was granted Performance-Based Restricted Stock Units (the "PBRSUs") in the target number of 2,500 shares (the "Target"), the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies disclosed in the Issuer's 2022 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.

F3 · derivative.expiration_date: On September 13, 2022, the Reporting Person was granted Performance-Based Restricted Stock Units (the "PBRSUs") in the target number of 2,500 shares (the "Target"), the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies disclosed in the Issuer's 2022 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.

SEC source: 0001415889-22-009611 · form4-09142022_010946.xml · derivative · entry 1

Deily Richard H · CIK 0001358787 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,334

Underlying: Common Stock · 12,500 shares

Expires not disclosed

F1 · derivative.exercise_date: On September 13, 2022, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 12,500 shares of common stock. The TBRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 9/13/2023.

F1 · derivative.expiration_date: On September 13, 2022, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 12,500 shares of common stock. The TBRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 9/13/2023.

F2 · balance_after: As of the date of this filing, the total number of TBRSUs beneficially owned by the Reporting Person includes (a) 2,334 shares of TBRSUs granted on April 16, 2021; (b) 3,500 shares of TBRSUs granted on April 18, 2022; and (c) 12,500 shares of TBRSUs granted on September 13, 2022. All are to vest pursuant to their respective three year vesting schedule similar to the one described in footnote 1 above.

SEC source: 0001415889-22-004769 · form4-05092022_040501.xml · nonDerivative · entry 1

Jeffrey John Ronald Jr. · CIK 0001709914 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · John R. Jeffrey, IRA

Disclosed balance after: 8,000

F1 · shares: On May 6, 2022, the Reporting Person purchased 1,000 shares of the Issuer's Common Stock on the open market at a price of $36.70 per share.